IL74535A - Antiviral pharmaceutical compositions containing lidocaine,prilocaine,etidocaine,mepivacaine or bupivacaine and method for the preparation thereof - Google Patents

Antiviral pharmaceutical compositions containing lidocaine,prilocaine,etidocaine,mepivacaine or bupivacaine and method for the preparation thereof

Info

Publication number
IL74535A
IL74535A IL74535A IL7453585A IL74535A IL 74535 A IL74535 A IL 74535A IL 74535 A IL74535 A IL 74535A IL 7453585 A IL7453585 A IL 7453585A IL 74535 A IL74535 A IL 74535A
Authority
IL
Israel
Prior art keywords
etidocaine
prilocaine
mepivacaine
bupivacaine
preparation
Prior art date
Application number
IL74535A
Other languages
English (en)
Other versions
IL74535A0 (en
Original Assignee
Brigham Dana
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Brigham Dana filed Critical Brigham Dana
Publication of IL74535A0 publication Critical patent/IL74535A0/xx
Publication of IL74535A publication Critical patent/IL74535A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL74535A 1984-03-08 1985-03-07 Antiviral pharmaceutical compositions containing lidocaine,prilocaine,etidocaine,mepivacaine or bupivacaine and method for the preparation thereof IL74535A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/587,398 US4628063A (en) 1984-03-08 1984-03-08 Antiviral pharmaceutical preparations and methods for their use

Publications (2)

Publication Number Publication Date
IL74535A0 IL74535A0 (en) 1985-06-30
IL74535A true IL74535A (en) 1988-12-30

Family

ID=24349633

Family Applications (1)

Application Number Title Priority Date Filing Date
IL74535A IL74535A (en) 1984-03-08 1985-03-07 Antiviral pharmaceutical compositions containing lidocaine,prilocaine,etidocaine,mepivacaine or bupivacaine and method for the preparation thereof

Country Status (13)

Country Link
US (2) US4628063A (de)
EP (1) EP0154344B1 (de)
JP (1) JPH0676317B2 (de)
AT (1) ATE91233T1 (de)
AU (1) AU571072B2 (de)
DE (1) DE3587434T2 (de)
ES (1) ES8700053A1 (de)
IE (1) IE61525B1 (de)
IL (1) IL74535A (de)
NZ (1) NZ211361A (de)
PT (1) PT80079B (de)
WO (1) WO1985003862A1 (de)
ZA (1) ZA851765B (de)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5380754A (en) * 1988-02-29 1995-01-10 Virotex Corporation Topical composition enhancing healing of viral lesions
US5284664A (en) * 1988-08-04 1994-02-08 Kremers-Urban Company Method of treating the symptoms of Alzheimer's disease
US5316775A (en) * 1988-08-04 1994-05-31 Kremers-Urban Company Method of treating hepatitis B infection
US5334395A (en) * 1988-08-04 1994-08-02 Kremers-Urban Company Method of treating an epstein-barr viral infection
US5055296A (en) * 1988-08-04 1991-10-08 Wagle Sudhakar S Method of treating chronic fatigue syndrome
SE8804214L (sv) * 1988-11-22 1990-05-23 Jean Cassuto Antiinflammatoriskt och antiinfektioest medikament
US4997853A (en) * 1988-12-02 1991-03-05 Galenpharma, Inc. Method and compositions utilizing capsaicin as an external analgesic
US5331012A (en) * 1990-07-30 1994-07-19 Riddick Kenneth B Topical pharmaceutical preparation for fever blisters and other viral infections and method of use
GB9027433D0 (en) * 1990-12-18 1991-02-06 Merrell Dow Pharma Anti-herpes castanospermine esters
JP3115625B2 (ja) * 1991-03-30 2000-12-11 帝國製薬株式会社 リドカイン含有外用貼付剤
HU212426B (en) * 1992-07-22 1996-06-28 Vepex Kft Process for producing bioactive pharmaceutical compositions
CA2130291A1 (en) * 1993-08-18 1995-02-19 Juan Carlos Mahiques Therapeutic uses of known ester and amide compounds
EP0643964A3 (de) * 1993-08-18 1995-08-09 Medipharma Sa Verwendung von Lokalanästhetika zur Herstellung eines Arzneimittels zum Schutz der Membran von Plasmazellen.
US5506236A (en) * 1994-04-28 1996-04-09 Schering Corporation 4-substituted pyrazoloquinoline derivatives
US5776859A (en) * 1995-11-15 1998-07-07 Nickel; Alfred A. Sodium channel active novel compounds and related processes and bioassay techniques
US5869446A (en) * 1996-07-09 1999-02-09 Gambit International Limited Preparation of lactoferrin (or serotransferrin or ovotransferrin) and desferrioxamine methanesulfonate (or other low molecular weight metal ion chelators) for the therapy of viral infections
DE19823319A1 (de) * 1998-05-26 1999-12-02 Karl Engelhard, Fabrik Pharm.- Praeparate Gmbh & Co. Kg Topisch anwendbares Arzneimittel zur Behandlung von Virusinfektionen
US6093417A (en) * 1999-01-11 2000-07-25 Advanced Medical Instruments Composition to treat ear disorders
US8512718B2 (en) 2000-07-03 2013-08-20 Foamix Ltd. Pharmaceutical composition for topical application
US20040076671A1 (en) * 2002-10-21 2004-04-22 Aletha Tippett Methods and compositions for topical wound treatment
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US8486376B2 (en) 2002-10-25 2013-07-16 Foamix Ltd. Moisturizing foam containing lanolin
MXPA05004278A (es) 2002-10-25 2005-10-05 Foamix Ltd Espuma cosmetica y farmaceutica.
US8119109B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Foamable compositions, kits and methods for hyperhidrosis
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
US7820145B2 (en) 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US8119150B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Non-flammable insecticide composition and uses thereof
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US7575739B2 (en) 2003-04-28 2009-08-18 Foamix Ltd. Foamable iodine composition
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
US8486374B2 (en) 2003-08-04 2013-07-16 Foamix Ltd. Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
CA2610662A1 (en) 2005-05-09 2007-05-18 Foamix Ltd. Foamable vehicle and pharmaceutical compositions thereof
ITRM20060163A1 (it) * 2006-03-24 2007-09-25 Ist Farmacoterapico It Spa Composizione spray ad uso topico per il tratamento e la prevenzione delle infezioni labiali da herpes simplex
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
WO2009069006A2 (en) 2007-11-30 2009-06-04 Foamix Ltd. Foam containing benzoyl peroxide
WO2010041141A2 (en) 2008-10-07 2010-04-15 Foamix Ltd. Oil-based foamable carriers and formulations
WO2009072007A2 (en) 2007-12-07 2009-06-11 Foamix Ltd. Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
CA2712120A1 (en) 2008-01-14 2009-07-23 Foamix Ltd. Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
US20120087872A1 (en) 2009-04-28 2012-04-12 Foamix Ltd. Foamable Vehicles and Pharmaceutical Compositions Comprising Aprotic Polar Solvents and Uses Thereof
WO2011013009A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
CA2769677A1 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
BR112012007473A2 (pt) 2009-10-02 2019-05-07 Foamix Ltd composições tópicas de tetraciclina e respectivo método de uso
US10398641B2 (en) 2016-09-08 2019-09-03 Foamix Pharmaceuticals Ltd. Compositions and methods for treating rosacea and acne
RU2634264C1 (ru) * 2016-09-19 2017-10-24 Александр Ливиевич Ураков Крем-молочко для лечения опоясывающего лишая
IT201800007009A1 (it) * 2018-07-06 2020-01-06 Nuovo uso medico di anestetici locali

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1315727A (fr) * 1961-06-13 1963-01-25 Perfectionnement aux véhicules-jouets
RO75309A2 (ro) * 1978-10-24 1981-12-25 Intreprinderea De Antibiotice,Ro Unguent medicamentos pentru tratamentul zonei zoster
FR2484257A1 (fr) * 1980-06-16 1981-12-18 Girard Michele Composition polyvitaminee pour le traitement de l'herpes

Also Published As

Publication number Publication date
ATE91233T1 (de) 1993-07-15
PT80079B (pt) 1987-09-18
AU4067385A (en) 1985-09-24
DE3587434T2 (de) 1994-02-17
EP0154344A3 (en) 1990-06-13
DE3587434D1 (de) 1993-08-12
IE61525B1 (en) 1994-11-16
US4757088A (en) 1988-07-12
IE850581L (en) 1985-09-08
WO1985003862A1 (en) 1985-09-12
ZA851765B (en) 1985-11-27
ES541103A0 (es) 1986-10-16
NZ211361A (en) 1988-07-28
ES8700053A1 (es) 1986-10-16
JPS61501325A (ja) 1986-07-03
EP0154344A2 (de) 1985-09-11
JPH0676317B2 (ja) 1994-09-28
IL74535A0 (en) 1985-06-30
PT80079A (en) 1985-04-01
EP0154344B1 (de) 1993-07-07
US4628063A (en) 1986-12-09
AU571072B2 (en) 1988-03-31

Similar Documents

Publication Publication Date Title
IL74535A (en) Antiviral pharmaceutical compositions containing lidocaine,prilocaine,etidocaine,mepivacaine or bupivacaine and method for the preparation thereof
DK198191A (da) Chlorsulfat
ATE53038T1 (de) Inositoltriphosphat, verfahren zu seiner herstellung und dieses enthaltende zubereitung.
HUT41718A (en) Process for preparing phenyl-carbamates and pharmaceutical compositions containing such compounds as active substances
ATE61050T1 (de) Pyridazinamine wirksam gegen viren.
CA2065285A1 (en) Antimalarial compositions
IT8149676A0 (it) Procedimento per la preparazione dicomposti pirimidinici dotati di attivita' farmacologica particolarmente per il trattamento di infezioni batteriche loro intermedi prodotto ottenuto e composizioni farmaceutiche che li contengono
DE69811062D1 (de) Polyaromatische antivirale zusammensetzungen
IT8123602A0 (it) Sali stabili della s-adenosilmetionina, processo per la loro preparazione e composizioni terapeutiche che li comprendono come principio attivo.
HUT38897A (en) Process for producing pharmaceutically active substituted benzamides and pharmaceutical compositions containing them as active agents
ES8600309A1 (es) Un procedimiento para preparar un isomero sin de un compuesto de cefem
DE3068530D1 (en) Pharmaceutical composition containing paracetamol, treatment pack comprising said composition and method of reducing liver toxicity effect of paracetamol compositions
IT1191050B (it) 2(1-alchil-5-nitro)-imidazolil-1-(2-idrossi-5-alchil)-fenil-carbinoli,loro metodo di preparazione e composizioni farmaceutiche che li contengono
ES2000681A6 (es) Un procedimiento para preparar nuevos compuestos de bencilpiperazina
JPS643185A (en) Active compound, its production and pharmaceutical composition containing same
BR8403973A (pt) Composicoes para combater insetos e representantes da ordem acarina,aplicacao,composto e processo para sua preparacao
JPS57102889A (en) 2'-(r)-substituted-2'-deoxyneplanocin a derivative
ES2010559A6 (es) Procedimiento de preparacion de composiciones farmaceuticas antivirales de aplicacion externa que se acumulan en la piel.
ES8303297A1 (es) Un procedimiento para la preparacion de un nuevo reptido activo.
IT1185525B (it) Derivait di amminodiarilsolfossidi,procedimento per la loro preparazione e composizioni farmaceutiche e pesticide che li contengono
JPS5716842A (en) Substance related to bestatin and its preparation
ES8506192A1 (es) Un metodo de producir extractos que contienen alergeno
MY100752A (en) Pharmaceutical composition for combating malaria.
JPS5742620A (en) Novel antiulcer agent
ES8305307A1 (es) Un procedimiento para la preparacion de un aciltripeptido.

Legal Events

Date Code Title Description
RH Patent void